By Prachi Patel-Predd


The Industry Insider: April 2007

August 13th 2010

Companies in the news: 1) AVAX and CTCA Collaborating for Cancer Therapies 2) Full Speed Ahead for GPC Biotech's Satraplatin 3) Bristol-Myers Squibb Company / Adnexus Therapeutics: Collaboration for New Oncology Compounds, and more

Politics & Policy: April 2007

August 13th 2010

This month's Fed Focus highlights such topics as Medicare reimbursement for cancer care and NCI budget cuts that affect cancer research.

GSK%u2019s Tykerb� Approved for Advanced Breast Cancer

August 12th 2010

With FDA approval for their advanced breast cancer drug Tykerb�, GlaxoSmithKline is poised to reposition itself as a major player in the oncology business.

Politics & Policy: May 2007

August 12th 2010

This month's Fed Focus highlights the CDC's HPV vaccine recommendations as well as changes in Medicare coverage of ESAs for cancer-related anemia. Our reports from

GSK%u2019s Cervical Cancer Vaccine Closer to Entering Market

August 11th 2010

GlaxoSmithKline%u2019s experimental cervical cancer vaccine Cervarix has proven 100% effective in preventing precancerous lesions due to cancer-causing human papillomavirus (HPV) strains 16 and 18 for up to five and a half years.

HRT Linked with Breast and Ovarian Cancers

July 12th 2010

Two separate studies show the relationship between hormone replacement therapy and women's cancers.

The Academy: June 16, 2010

June 16th 2010

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery. In this issue: Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Harvard Medical School, Boston; Dana-Farber Cancer Institute, Boston; Yale School of Medicine, New Haven; and Robert Wood Johnson Medical School,Piscataway, NJ.